Somerville, MA, United States of America

Matthew R Henn

This inventor holds 28 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Microbial Compositions. Top assignees: Seres Therapeutics, Inc., Seres Health, Inc.. Active years: 2014-2026.

USPTO Granted Patents = 28 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.6

ph-index = 13

Forward Citations = 1,072(Granted Patents)


Location History:

  • Someville, MA (US) (2015)
  • Somerville, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bacterial Compositions
Clostridium Difficile
Microbial Treatments
Gastrointestinal Health
Immune System Disorders
Synergistic Compositions
Network-Based Microbiology
Methods of Production
28 patents (USPTO):Explore Patents

Title: The Innovative Mind of Matthew R Henn

Introduction: Matthew R Henn, a talented inventor based in Somerville, MA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Matthew R Henn holds several patents in various technological fields, including but not limited to artificial intelligence, renewable energy, and medical devices.

Career Highlights: Throughout his career, Matthew R Henn has been recognized for his innovative thinking and problem-solving skills. He has received numerous awards for his contributions to the tech industry.

Collaborations: Matthew R Henn has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to successful projects and products.

Conclusion: Matthew R Henn continues to push the boundaries of innovation, inspiring others in the tech industry with his creativity and dedication to making the world a better place through his inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…